Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Clinical trial NCT07016165 · RECRUITING

Trial details

NCT number: NCT07016165
Sponsor: Gadjah Mada University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Neutropenic Fever Acute Lymphoblastic Leukemia Acute Myeloblastic Leukemia Non Hodgkin Lymphoma

Start date: 2025-06-01
Primary completion: 2025-11-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.